BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29739299)

  • 1. GRP137 promotes cell proliferation and metastasis through regulation of the PI3K/AKT pathway in human ovarian cancer.
    Zhang LQ; Yang SQ; Qu XD; Chen XJ; Lu HS; Wang Y
    Tumori; 2018 Oct; 104(5):330-337. PubMed ID: 29739299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAK5 Induces EMT and Promotes Cell Migration and Invasion by Activating the PI3K/AKT Pathway in Ovarian Cancer.
    Li D; Pan Y; Huang Y; Zhang P; Fang X
    Anal Cell Pathol (Amst); 2018; 2018():8073124. PubMed ID: 30245957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
    Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y
    Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
    Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J
    J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-198 inhibits proliferation, invasion and migration of ovarian cancer cells by regulating the PI3K/Akt signaling pathway.
    Xiao H; Zheng Y; Chen J; Shen H
    Acta Biochim Pol; 2021 Jun; 68(4):673-677. PubMed ID: 34181826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway.
    Shen F; Zong ZH; Liu Y; Chen S; Sheng XJ; Zhao Y
    Biomed Pharmacother; 2019 Jun; 114():108787. PubMed ID: 30925458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA MIR4697HG Promotes Cell Growth and Metastasis in Human Ovarian Cancer.
    Zhang LQ; Yang SQ; Wang Y; Fang Q; Chen XJ; Lu HS; Zhao LP
    Anal Cell Pathol (Amst); 2017; 2017():8267863. PubMed ID: 28168162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of shRNA-mediated knockdown of SPOCK1 on ovarian cancer growth and metastasis.
    Zhang LQ; Wang Y; Zhang L
    Cell Mol Biol (Noisy-le-grand); 2015 Nov; 61(7):102-9. PubMed ID: 26638890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of PI3K/Akt/NF-κB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer].
    Xu CL; Lu XL; Yan XN; Wang HL; Chen SQ
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):134-8. PubMed ID: 22455747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.
    Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Macdonald E; Vanderhyden B; Bachvarov D
    Oncotarget; 2016 Mar; 7(12):14125-42. PubMed ID: 26871602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway.
    Zhang LQ; Yang HQ; Yang SQ; Wang Y; Chen XJ; Lu HS; Zhao LP
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819874773. PubMed ID: 31537175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
    Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
    Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivo.
    Gao M; Ma Y; Bast RC; Li Y; Wan L; Liu Y; Sun Y; Fang Z; Zhang L; Wang X; Wei Z
    Med Oncol; 2016 Jul; 33(7):73. PubMed ID: 27277757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoplasmic reticulum stress regulates proliferation, migration and invasion of human ovarian cancer SKOV3 cells through PI3K/AKT/mTOR signaling pathway.
    Yang N; Qu YJ; Cheng Y; Liang T; Zhang MN; Zhang D; Dong LN; Wang XW; Zhang GM
    Cancer Biomark; 2017 Jul; 19(3):263-269. PubMed ID: 28453460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
    Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
    Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Girinimbine Inhibits the Proliferation of Human Ovarian Cancer Cells In Vitro via the Phosphatidylinositol-3-Kinase (PI3K)/Akt and the Mammalian Target of Rapamycin (mTOR) and Wnt/β-Catenin Signaling Pathways.
    Xin Q; Muer A
    Med Sci Monit; 2018 Aug; 24():5480-5487. PubMed ID: 30084434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.